Document Detail

Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis.
MedLine Citation:
PMID:  22388646     Owner:  NLM     Status:  Publisher    
PURPOSE OF REVIEW: Biologics targeting tumor necrosis factor (TNF) has revolutionized the treatment of rheumatoid arthritis (RA) and clinical remission becomes a realistic treatment goal. After achieving remission, discontinuation of TNF inhibitors may become an important issue from viewing points of safety and economy. However, there is not well established firm evidence regarding biologic-free remission. We here document whether 'treatment holiday' of TNF inhibitors is possible in RA patients, after maintaining low disease activity by intensive treatment with TNF inhibitors. RECENT FINDINGS: From European studies such as BeSt and OPTIMA in patients with early RA and Japanese studies such as RRR and HONOR in patients with established RA, after reduction of disease activity to clinical remission or low disease activity in patients with RA by infliximab or adalimumab in combination with methotrexate, some patients could successfully remain in clinical remission without TNF inhibitors for 6 months or 1 year and without radiologic and functional progression of articular destruction. SUMMARY: After maintaining low disease activity by intensive treatment with TNF inhibitors, discontinuation of TNF inhibitors without disease flare, joint damage progression and functional impairment, treatment holiday, is possible in some RA patients.
Yoshiya Tanaka
Related Documents :
2430416 - Vulval lichen sclerosus et atrophicus treated with etretinate (tigason).
21601496 - Risk of laryngeal edema and facial swellings after tooth extraction in patients with he...
16818296 - Differences in reasons for smoking between younger and older smokers.
25491046 - Clinical evolution after a non-reactive hypothermic eeg following cardiac arrest.
3339166 - Parasympathetic and sympathetic alterations of mobitz type ii heart block.
10700716 - The effect of thyrotoxicosis on adrenocortical reserve.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-1
Journal Detail:
Title:  Current opinion in rheumatology     Volume:  -     ISSN:  1531-6963     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000851     Medline TA:  Curr Opin Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Advances in imaging.
Next Document:  Clinical Relevance of a Routinely Performed Magnetic Resonance Cholangiopancreatography (MRCP) Prior...